Searchable abstracts of presentations at key conferences in endocrinology

ea0056mte5 | (1) | ECE2018

Medullary thyroid cancer beyond surgery

Maia Ana Luiza

Medullary thyroid carcinoma (MTC) is a rare thyroid C cell malignant tumor that accounts for 3-4% of thyroid gland neoplasias. MTC may occur sporadically or be inherited. Hereditary MTC appears as part of the MEN 2 syndrome. Germ-line mutations of the RET proto-oncogene cause hereditary cancer, whereas somatic mutations are frequently present in sporadic disease. Currently, early MTC diagnosis followed by total thyroidectomy offers the only possibility of the cure of the disea...

ea0016p232 | Diabetes and cardiovascular diseases | ECE2008

Severity of depression in patients with type 1 and type 2 diabetes and its relation to the level of glycemia control and anti-depressive therapy

Tsutskiridze Liana , Kurashvili Ramaz , Asatiani Natalia , Kurashvili Givi , Khelashvili Maia , Nishnianidze Maia , Shelestova Elena , Dundua Mzia

Background and aims: There are consistent findings about increased prevalence of depressive disorders in diabetes. The aim of the study was to reveal prevalence of depression in patients (pts) with type 1 (DM1) and type 2 (DM2) diabetes.Materials and methods: Totally, 157 pts with DM were questioned. To assess depression degree Beck’s scale was used, and 83 depressive pts (scores>10), were allocated into 2 groups (Gr.): Gr.1 (n=44)-DM2 pt...

ea0037gp.28.06 | Endocrine tumours and neoplasia – NETS | ECE2015

Patient-reported time to diagnosis of neuroendocrine tumors (NETs) in Europe: results from the first global NET patient survey: a collaboration between the International Neuroendocrine Cancer Alliance (INCA) and Novartis

Pavel Marianne , Kolarova Teodora , Goldstein Grace , Leyden John , Sissons Maia

Background: Neuroendocrine tumor (NET) symptoms are often similar to common conditions or may not arise until metastasis occurs, delaying diagnosis and impacting survival. We present data on time to diagnosis from the European (EU) NET patient perspective.Methods: In 2014, 1928 NET patients from >12 countries (Europe (n=763): Belgium, Bulgaria, France, Germany, Norway, UK, and other EU countries (not specified); Americas; Asia; Oceania) part...

ea0037ep1139 | Endocrine tumours | ECE2015

Neuroendocrine tumor European patient experience: results from the first global NET patient survey – a collaboration between the International Neuroendocrine Cancer Alliance and Novartis

Oberg Kjell , Leyden John , Goldstein Grace , Sissons Maia , Kolarova Teodora

Background: NETs are a rare heterogeneous group of malignancies, often with a delayed diagnosis. Although diagnosis of NETs is increasing (due in part to greater awareness), little has been published on the NET patient experience. We present data on the EU NET patient perspective.Methods: In 2014, 1928 NET patients from >12 countries, including EU (n=763: Belgium, Bulgaria, France, Germany, Norway, UK, other EU countries (not specified by re...

ea0081p213 | Thyroid | ECE2022

Tuberculosis and myxedema coma − clinical case

Saraiva Miguel , Maia Ariana , Assuncao Guilherme , Amaral Claudia , Freitas Claudia , Couto de Carvalho Andre

Introduction: Myxedema coma is the ultimate stage of severe long-standing hypothyroidism, representing a true endocrinological emergency. Many precipitating factors have been identified, including the initiation of certain drugs.Case report: An 89-year-old woman was admitted to our emergency department due to an inaugural seizure. There was a history of progressive functional deterioration in the last 7 weeks, short after being diagnosed with lymph node ...

ea0086p91 | Neuroendocrinology and Pituitary | SFEBES2022

Diabetes insipidus safety: Automated electronic records alert to identify patients with diabetes insipidus in hospital

Clave Llavall Anna , Aquino Maia , Teo James , Mustafa Omar G. , Whitelaw Benjamin C.

Background: Cranial diabetes insipidus (DI) is characterised by the inability to produce vasopressin leading to uncontrolled diuresis. Management includes administering synthetic vasopressin analogue desmopressin (DDAVP). Recently, there have been several national reports of DDAVP omission causing serious patient harm. This study aims to evaluate the feasibility of an automated alert system using Natural Language Processing (NLP) in electronic health records (EHR) to detect DI...

ea0090ep206 | Calcium and Bone | ECE2023

Severe PTH-dependent Hypercalcemia Secondary to Atypical Parathyroid Adenoma

Maia Ariana , Fonseca Liliana , Viveiros Ana Luisa , Neves Joao , Cardoso Helena

Introduction: Hypercalcemia is not uncommon in clinical practice and may present as a life-threatening emergency. Its main aetiologies are primary hyperparathyroidism (80% parathyroid adenomas; 20% multiglandular hyperplasia, <1% parathyroid carcinomas) and hypercalcemia of malignancy, with or without presence of bone metastases.Case Report: We present a case of a 77 years-old male, submitted to a subtotal gastrectomy at the age of 73 due to a perfor...

ea0049gp234 | Thyroid Cancer | ECE2017

Lobectomy as a treatment option for well differentiated thyroid cancer (WDTC) between 1–4 cm: which results should we expect?

Fareleira Ana , Ferreira Patricia Andrea , Lima L Matos , Maia J Costa

Introduction: The ATA guidelines 2015 suggests lobectomy as an option for low risk thyroid tumors between 1–4 cm, although there remains some controversy once some characteristics become apparent only on pathologic examination.Objective/methods: Retrospective analysis of patients who underwent thyroid surgery in 2014 and 2015, with a histologic diagnosis of WDTC 1–4 cm in size and revision of the proportion of patients eligible for lobectomy wi...

ea0041ep781 | Obesity | ECE2016

Bariatric surgery: a health economic perspective of the prescription costs

Paredes Silvia , Pereira Maria Lopes , Fernandes Aline , Manso Fernando , da Costa Maia , Marques Olinda , Alves Marta

Introduction: The economic burden of obesity on healthcare systems is increasing. Bariatric surgery leads to considerable weight loss and health improvement. However, this surgery is costly and doubts about its affordability have been raised. Few studies have assessed outcomes such as drug use and costs after bariatric surgery. The aim of this study was to evaluate drug consumption and costs before and after bariatric surgery.Methods: Retrospectively, da...

ea0038p64 | Clinical practice/governance and case reports | SFEBES2015

Resistant hypocalcaemia secondary to denosumab: two case reports

Clay Caroline , Ho Jan Hoong , Severn Maia , Kaushal Kalpana , Howell Simon

Case 1: A 65-year-old man was admitted with symptomatic hypocalcaemia (corrected calcium of 1.65 mmol/l, PTH 46.6 (1.6–6.8) pmol/l, and vitamin D 51.4 (50–150) nmol/l)) 5 days following denosumab initiation. He had a diagnosis of probable urothelial carcinoma with associated osteoblastic metastases, and 10 days prior to this admission had been treated for hypercalcaemia (corrected calcium of 3.04 (2.20–2.60) mmol/l) with i.v. fluids following which denosumab was...